Medicamen Biotech standalone net profit declines 1.96% in the September 2014 quarter

Sales rise 34.07% to Rs 27.31 crore

Net profit of Medicamen Biotech declined 1.96% to Rs 0.50 crore in the quarter ended September 2014 as against Rs 0.51 crore during the previous quarter ended September 2013. Sales rose 34.07% to Rs 27.31 crore in the quarter ended September 2014 as against Rs 20.37 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales27.3120.37 34 OPM %6.199.47 -PBDT1.141.15 -1 PBT0.610.74 -18 NP0.500.51 -2

Powered by Capital Market - Live News